Intratracheal instillations of 7H-dibenzo(c, g)carbazole (DBC), a tobacco smoke component , into Syrian golden hamsters, resulted in preneoplastic lesions and benign and malignant respiratory neoplasms. Neoplastic progression was associated with speci c changes in the extracellular matrix (ECM), dependen t on the stage of tumor development . DBC-induced tracheobronchia l squamous metaplasia was associated with an increase in collagen type I and type III deposition in the subepithelial ECM, as observed by computer-assisted image analysis of immunohistochemica l staining for the aminoterminal propeptides of collagen type I (PINP) and collagen type III (PIIINP). Increased collagen matrix synthesis was detected in dysplasia by in situ hybridization of a 1(I) mRNA for collagen I and a 1(III) mRNA for collagen type III after continued exposure to DBC. In welldifferentiated squamous cell carcinomas with an expansive growth pattern, collagen deposition increased, as did ber size. In moderately differentiated neoplasms, basement membrane (BM) destruction and invasion was associated with a destructive growth pattern and decreases in collagen synthesis and the deposition of new collagen. Preserved deposition of mature collagen was detected by staining for the telopeptide of collagen type I propeptide.
INTRODUCTION
Studies of the causes, pathogenesis, development and behavior of human respiratory neoplasms pose problems inherent to the nature of these tumors. They are rapidly fatal if untreated and ethical considerations prevent any follow-up of uninterrupted neoplastic progression. The hamster intratracheal instillation model (51) has been shown to be effective in producing tumors similar to those found in man (60) . When given with ferric oxide (Fe 2 O 3 ), polycyclic hydrocarbons, including benzo (a) pyrene (B(a)P), cause a high incidence of respiratory tract tumors (23, 36, 51, 52, 56, 57, 60) . Because 7H-dibenzo[c,g]carbazole (DBC) also induces a high incidence of malignant tumors in the upper and lower respiratory tract when given alone (57) , we used this model to study the mechanisms of respiratory carcinogenesis, tumor induction, development and progression.
The role of exogenous agents in respiratory tumor induction has been extensively analyzed in epidemiological studies. However, less is known of the action of speci c agents in the development and progression of these tumors. Hoffmann and Wynder (24) reported that smoke from 100 cigarettes contained 0.7 l g DBC and 3.9 l g BaP. The presence of DBC in tobacco tar and in petroleum combustion products (68, 69) makes this compound of interest in studies of human exposure to environmental agents.
Tracheobronchial and alveolar epithelial structures have received most attention in the study of respiratory carcino-genesis. The extracellular matrix (ECM) has been less considered, and then mainly as a supportive structure, although it actively participates in tumor development in many organs (26) . The bulk of the collagen matrix consists of interstitial collagen types I and III (14, (44) (45) (46) (47) . The ber-forming interstitial type I and type III collagens are synthesized as procollagens, containing propeptide domains at both ends of the molecule, that are usually cleaved off en bloc during secretion into the ECM (14, 46) . The antibodies used in this study were against the aminoterminal propeptide of type I procollagen (PINP), and the aminoterminal propeptide of type III procollagen (PIIINP), also known as type I and type III pN collagen (33) . PINP is mainly present in newly synthesized collagen containing the aminoterminal propeptide (72) . Antibodies to the cross-linked carboxyterminal telopeptide of type I collagen (ICTP) can be used to measure cross-linked mature type I collagen in human tissue (44) and degradation products of collagen type I (34, 44) . The antibody to collagen type III propeptide (PIIINP) binds to newly synthesized collagen, whose location and quantity are comparable to those of mature collagen (47, 73) . In tissues, some of the type III collagen retains its aminoterminal propeptide when incorporated into bers (13) . Immunoassays for different collagen components as well as immunohistochemical studies on collagen expression have shown clinical usefulness in studies on neoplasms in different organs (26, 47, 64, 72, 73) .
The occurrence and location of growth factors regulate many cellular functions, including cell proliferation and collagen deposition. Growth factors of the TGFb family are highly potent growth regulators of epithelial cell proliferation and differentiation (4, 7, 8, 20, 49, 50, 59) . In vivo, TGFb genes are expressed in embryonic epithelia undergoing critical stages of tissue morphogenesis and/or epithelial differentiation (12, 16, 22, 38) . TGFb also plays a crucial role in the regulation of cell proliferation, differentiation and chemotaxis (37, 39) . Overexpression of TGFb has been associated with malignant progression (20, 25) and an unfavorable prognosis of neoplasms (21) . TGFb regulates epithelial-mesenchymal interactions and acts as an endogenous regulator of epithelial homeostasis (20) . It also accelerates wound healing (29) . In vitro, TGFb stimulates ECM production in response to external stimuli, including mitogens and differentiating agents (31) . Through these profound effects on connective tissue biosynthesis, TGFb may play a signi cant role in the development of normal and tumor stroma.
Analysis of speci c cellular changes is feasible in immunohistochemical studies, allowing distinction of morphological entities. However, histoscores and similar systems are difcult to apply to large series with suf cient reproducibility, hindering statistical analysis of the results (5, 53) . Computerassisted image cytometry has been proposed as a means to solve these problems (17, 35) and it has gained acceptance in analysis of hormone receptors, cell proliferation (10, 40, 43) , and ploidy (2) . Clinical applications in tumor prognostication have also been proposed. Variability in automated image analysis occurs, and Reeder et al (42) reported signi cant differences to be due to specimen variability in sampling. Studies involving controlled conditions and de ned endpoints are few.
In this study, we report on the role of matrix constituents and the signi cance of changes in collagen structure and location in relation to sensitivity as regards tumor formation, the structure of respiratory epithelium, as well as neoplasm development and behavior. The distribution and expression of newly formed collagen type I (via analysis of PINP), mature, cross-linked collagen type I (via ICTP), and newly formed collagen type III (via PIIINP) was studied by immunohistochemistry and compared with results obtained from staining of reticulin using conventional staining methods. Collagen synthesis was evaluated by in situ hybridization of collagen a 1(I) mRNA, a 2(I) mRNA, and a 1(III) mRNA. The results were analyzed using computer-assisted image analysis in a CAS-200 system, providing a method for the detailed analysis of minor alterations in large numbers of cellular structures. MATERIALS AND METHODS In this study, 192 8-week-old Syrian hamsters were divided into 4 groups as previously published (57) . The animals were randomly bred in the Eppley colony, supervised by an animal control committee. The experiments were carried out according to standard procedures, following appropriate regulations. The chemical, DBC (Aldrich Chemical Co, Milwaukee, Wisconsin, USA), was 99% pure. Treatments were carried out as previously described (57) . Group 1 received a weekly instillation of 3.0 mg DBC in 0.2 ml water for 10 weeks and group 2, 0.5 mg for 18 weeks. Group 3 received distilled water and group 4 was kept as an untreated control group. The animals were weighed weekly and allowed to die spontaneousl y or were sacri ced when moribund. At autopsy, the tracheas were ligated; the lungs, while still fully expanded, were removed en bloc and then xed in 10% neutral-buffered formalin for an extended period of time.
Specimens
Paraf n-embedded specimens were cut ve-l m-thick, and sections stained with hematoxylineosin and other stains, including periodic acid-Schiff (PAS), PAS after diastase treatment (dPAS), Mayer's mucicarmine, toluidine blue, and 1% alcian blue at different pHs. Masson's trichrome stain and van Gieson's stain were used to study the connective tissue components, acid-orcein-Giemsa stain to demonstrate elastic bers, and Gomori's silver impregnation for reticular bers.
Antibodies
The antibodies used are listed in Table 1 and the conditions of use in Table 2 . Antibodies used in this study included polyclonal antibodies against human collagens, raised in rabbits (33, 44) . Antibodies to PINP (0.428 mg IgG/ml) were prepared from the ascitic uid of a patient with pancreatic carcinoma (33, 72) . Antibodies to ICTP (0.104 mg IgG/ml) were prepared by using human bone as starting material (48) . Antibodies to PIIINP (0.808 mg IgG/ml) were produced as described previously (33, 73) . Cross-reactivity between human and hamster tissues was con rmed, using human and mouse tissues as controls. Antibodies to TGFb were obtained commercially (Santa Cruz Biotechnology Inc, Santa Cruz, California, USA), and used according to the supplier's instructions. The antibodies were polyclonal IgG rabbit antibodies, non cross-reactive with other isoforms. The TGFb 1 antibody (sc 146) identi ed an epitope mapping at the carboxyterminal of TGFb 1 of human origin, identical to corresponding rodent sequence. As blocking peptide, TGFb 1 was obtained from Life Technologies (Gaithersburg, Maryland, USA). The TGFb 2 antibody, sc 90, also identi ed an epitope mapping at the carboxyterminus of TGFb 2 of human origin. The TGFb 3 antibody, sc 82, also identi ed an epitope mapping at the carboxyterminus of TGFb 3 of human origin, identical to corresponding mouse and chicken sequences. For comparison, the same TGFb isomers were used as previously described (19) . For b identi cation of myo broblasts, antibodies to smooth muscle actin (SMA) (Dako Co, Glostrup, Denmark) were used according to the supplier's recommendations. Antibodies to p53 (CM5) were obtained from Novocastra (Newcastle, Great Britain) and proliferating nuclear antigen (PCNA) antibody PC10 was from Dako Co (Glostrup, Denmark). They were used as previously described (61) . For identi cation of various cell types, commercially available antibodies against cytokeratins, Ma 903 (Enzo Diagnostics, Farringdale, New York, USA), MNF 116 (Dako Co, Glostrup, Denmark) and Mac 6 (Triton Diagnostics, Alameda, California, USA) were used according to the suppliers' instructions.
Immunohistochemical Methods
Immunohistochemistry and in situ hybridization were performed as described previously (19, 26, 27, 62) . Several different immunohistochemical methods were used in the study, employing different experimental conditions as well as numerous controls at different steps. The applicability of the antibodies for hamster tissues was veri ed using different human, mouse and hamster tissues as controls.
In situ Hybridization
The probes used for in situ hybridization in this study were prepared for use in studies on humans (26, 27) . These probes required fairly stringent conditions for adequate function. Hence human control tissues were also extensively used, giving comparable results. A 372-bp Pstl-Pvull fragment of the cDNA corresponding to part of the carboxyterminal propeptide domain of the human proa 1(I) chain cloned in plasmid pHCAL1U, and a 379-bp Pstl-PStl fragment of the cDNA covering part of the triple-helical domain as well as the carboxyterminal telopeptide and propeptide parts of the human proa 1(III) chain, cloned in plasmid pHFS3, were subcloned into the polylinker site of pGEM1 vectors (Promega, Madison, Wisconsin, USA). A 571-bp Xbal-Pstl fragment coding for part of the triple helical domain as well as for the carboxyterminal telopeptide and propeptide domains of the human proa 2(I) chain cloned into plasmid Hf1131, was prepared by restriction enzyme digestion of the cDNA, and subcloned into the polylinker site of pBluescript (SK-) vectors (Stratagene, La Jolla, California, USA). The authenticity of the inserts was veri ed by sequencing (Pharmacia sequencing kit, Pharmacia, Uppsala, Sweden). A riboprobe transcription kit (Promega, Madison, Wisconsin, USA) was used for transcription. Sense and antisense RNA probes were labelled with 35 S UTP (Amersham, Little Chalfont, UK). The sense probes were used for detecting nonspeci c binding of RNA to the tissue. All the solutions and glassware used with the RNA probes were pretreated with 0.1% diethylpyrocarbonate (Sigma Chemical Co, St. Louis, Missouri, USA).
In situ hybridization was carried out as described previously (27) , using both radioactive and digoxigenin procedures. Formalin-xed, paraf n-embedded tissue sections were deparaf nized and pretreated with 0.2 M HCl for 7 minutes at room temperature, followed by a 5-minute wash in water and digestion with proteinase K (1 mg/ml) (Boehringer Mannheim, Mannheim, Germany) in PBS, pH 7.2, for 30 minutes at 37 C.
The sections were then dipped in 0.2% glycine in PBS at room temperature and washed twice with PBS for 30 seconds and 5 minutes, respectively. The sections were acetylated in 0.5% acetic anhydride in 0.1 M triethanolamine for 10 minutes, at room temperature. After a 5-minute wash in PBS and dehydration in an increasing series of ethanol concentrations, the sections were allowed to air-dry for 2 hours, or overnight, at room temperature. Prehybridization was carried out with 50% formamide, 10% dextran sulfate, 0.3 M NaCl, 10 mM Tris-HCl, pH 8.0, 10 mM Na 3 PO 4 , 5 mM EDTA, 10 mM dithiothreitol, yeast tRNA (1 mg/ml), 0.02% (w/v) Ficoll, 0.02% (w/v) polyvinylpyrrolidone , and bovine serum albumin (0.2 mg/ml). Prehybridization took place at 50 C, for 2 to 3 hours. The sections were then washed in PBS, dehydrated, and air-dried. The hybridization mixture contained all the constituents of the prehybridization mixture plus the speci c probe. The probe was denatured by boiling for 1 minute and then placed on ice, and 1 Hl (40 U) of ribonuclease inhibitor (Promega, Madison, Wisconsin, USA) was added. A 40 l l aliquot of the hybridization mixture (containing approximately 3 10 6 cpm 35 S) was placed on each section, and the sections were covered with Para lm (American National Can, Greenwich, CT, USA). Hybridization took place overnight at 50 C in a moist chamber. The sections were then washed 3 times, for 45 minutes each, at 50 C, in a buffer containing all of the constituents of the hybridization mixture except for dextran sulfate and tRNA. The slides were then washed in 0.5 M NaCl in 10 mM Tris-HCl, pH 7.5, and 1 mM EDTA at 37 C, for 15 minutes. The next wash contained 40 l g RNAse A/ml (Sigma Chemical Co, St. Louis, Missouri, USA) in the same buffer, to remove any nonspecifically bound single-stranded probe and the incubation was continued for 30 minutes. Sections were then washed in 0.5 M NaCl in Tris-EDTA at 37 C for 15 minutes, rinsed in 0.3 M NaCl in 0.03 M sodium citrate for 15 minutes at 45 C and, nally, in 0.075 M NaCl, 0.0075 M sodium citrate for 15 minutes at 60 C. After the washes, the sections were dehydrated in a graded series of ethanol containing 300 mM ammonium acetate and were air-dried at room temperature, overnight. Hybridization was detected by autoradiography after dipping the slides into NTB-3 nuclear track emulsion (Eastman Kodak, Rochester, New York, USA), melted at 42 C and diluted 1:1 with 1% glycerol. After drying for 1 hour at room temperature, the slides were kept in desiccantcontaining boxes at 4 C, for 8 to 14 days. The exposed slides were developed in distilled water, xed in Kodak AGEFIX for 5 minutes, and rinsed in distilled water. The slides were counterstained with hematoxylin and eosin.
The digoxin modi cation was otherwise similar except that digoxigenin-11-uridine-5-triphosphat e was used as substrate and for RNA labeling to replace UTP in in vitro localization, and Fast-Red tablets were used for signal detection. The NTP labeling mixture contained 10 mM ATP, GTP, CTP each, and 6.5 mM UTP, 3.5 mM digoxigenin-3-Omethylcarbonyl-e -aminocaproyl-[ 5-( 3-aminoallyl )uridine-5 -phosphate]tetralithium salt in Tris-neutralized solution, ph7,5 (Boehringer-Mannheim, Mannheim, Germany). For detection of digoxin-labeled compounds anti-digoxin-AP, fragments were used. For this purpose Fab fragments from an anti-digoxigenin antibody from sheep was conjugated with alkaline phosphatase (AP) (Boehringer-Mannheim, Mannheim, Germany). After immunization with digoxigenin the sheep IgG was puri ed by ion exchange chromatography and the speci c IgG was isolated by immunoabsorption. The Fab fragments obtained by papain digestion were conjugated with AP and stabilized in 50 mM triethanolamine buffer, 3mM NaCl, 1 mM MgCl2, 1% bovine serum albumin, pH 7.6. Subsequently dilution in 100 mM NaCl, pH 7.5 was performed. For detection Fast Red tablets containing 0.5. mg. naphtol substrate, 2 mg. Fast Red Chromate and 0.4 mg of levamisole as inhibitor of endogenous alkaline phosphatase were used.
Transmission Electron Microscopy
Fresh tissue was xed in 3% glutaraldehyde in 0.1 M phosphate buffer, pH 7.4, post xed in 1% osmium tetroxide in the same buffer, dehydrated in acetone and embedded in Epon LX 112. Sections of 1 l m were cut and stained with 1% toluidine blue for orientation by light microscopy. Ultrathin sections were cut with a Reichert Ultracut E-ultramicrotome (Reichert-Jung, Vienna, Austria), stained with uranyl acetate and lead citrate, and examined in a Philips TEM 410 LS transmission electron microscope.
Morphometry
Quantitative densitometry was performed using a CAS200 (Becton-Dickinson, Leiden, The Netherlands) automated image analyzer and the proprietary software, which was modi ed for this study. The specimens were analyzed and classied on the basis of absorbance analysis, using two simultaneously recorded videocamera images processed via computer using standard software. Immunoreactivity was quanti ed on the basis of the assumption that the total absorbance was directly proportional to the immunoreactivity. The microscope camera was operated utilizing the Lambert-Beer law, using applicable calibration and controls yielding appropriate linearity between light and dark settings. The measurements were made at wavelengths of 500 and 620 nanometers.
Total collagen deposition was estimated by determining the size of the area with positive staining exceeding a preset threshold level and reporting the ratio of the area relative to the total area analyzed. The procedure was carried out using a modi cation of the QPI program (Becton-Dickinson, Leiden, The Netherlands) as follows: The appropriate background light intensity and corresponding antibody levels were calibrated. Negative bers were selected from appropriate areas of the specimen. Measurements were recorded for bers fullling the criteria of morphological alteration, thus excluding contaminating populations. Absolute values of total optical density, indicating antibody-staining intensity, were recorded and reported as such. Staining intensity, shape, size and location of individual bers were also assessed, using a modication of the CMP program (Becton-Dickinson, Leiden, The Netherlands). The procedure was carried out as follows: Each ber was measured by using the "classify" function. Background light was calibrated using the automated function. Background thresholds and antibody thresholds were set on the basis of visual inspection. As the background control, the total area was measured and the same procedure was repeated with the antibody-treated area. The total area measured exceeded 65, 536 pixels. Fiber size, the shape factor (the ratio of squared perimeter to cell area), determining ber irregularity, and the integrated optical density, determining antibody staining intensity, were recorded.
Statistical Methods
Statistical analysis of the signi cance of alterations of cell properties in different lesions was performed using SPSS for Windows Release 8.0.1 (SPSS Inc, Chicago, Illinois USA). Means, standard deviations and 95% con dence intervals of means were calculated for size, shape, and intensity of individual collagen-staining bers in different lesions. Tests for normality were carried out using the Kolmogorov-Smirnov test. When normality tests were passed, one-way ANOVA as well as the Kruskall-Wallis H test were used. When Levene's test for homogeneity of variance was signi cant, Dunnett's T3 test was used for post hoc pair-wise analysis. Statistical comparison of areas of positive staining in different lesions was carried out after the Kolmogorov-Smirnov test showed normality of the data. One-way ANOVA was signi cant ( p 0.008), as was the Kruskall-Wallis H-test ( p 0.016), showing differences between groups. With Levene's test for homogeneity of variance signi cant ( p 0.024), Dunnett's T3 test was used for post hoc pair-wise analysis, and no signi cant differences between pairs were detected. Regression analysis showed the correlation between collagen shape and size to be statistically signi cant (Pearson's correlation coef cient 0.74; p < 0.0005).
RESULTS

Tumor Development
The incidences of the different types of respiratory tract tumor encountered in this study are shown in Figure 1 . The respiratory tumor incidence was high in groups 1 and 2. In group 1, a total dose of 30 mg caused 27 tumors in 19 out of 45 animals, the tumors being located mainly in the trachea and bronchi. The mean latency period for tumors in group 1 was 41 weeks. The rst tumor, a squamous cell carcinoma of the larynx, was seen in an animal that died at week 31. In group 2 a total dose of 9 mg caused tumors in 33 of 45 animals. Many animals had multiple tumors, yielding a total of 72 tumors in this group. Most of the tumors (55%) were located in the trachea and bronchi. The mean latency period in group 2 was 32 weeks, the rst malignant tumor being seen in the trachea at week 26. In both groups, the morphological types were mainly papillomas and squamous cell carcinomas, with a small number of adenocarcinomas and neoplasms of the pulmonary lining.
Tracheobronchia l Preneoplastic Lesions
Tracheobronchial epithelium exposed to DBC showed a number of preneoplastic and neoplastic lesions with associated alterations of the ECM. The rst changes appearing in DBC-exposed upper respiratory tract (larynx and trachea) were squamous metaplasia, basal cell hyperplasia and dysplasia (Figure 2A ). Collagen synthesis was increased in DBC-induced dysplasia, as re ected in an increased number of grains in the subepithelial ECM in in situ hybridization ( Figure 2B ), indicating accumulation of type I procollagen mRNA.
Basement membrane thickening and disruption ( Figure 3A) were associated with an increase in collagens, increasing in extent with severity, from moderate ( Figure 3B ) to severe. Expression of smooth muscle antigen-positive myo broblasts also increased in dysplasia ( Figure 3C ).
Tracheobronchia l Benign Tumors
The rst tracheobronchial tumors to appear were papillomas ( Figure 2C ), consisting of proliferating epithelium ultimately invading the stroma. The connective tissue stalk contained PINP-positive type I collagen and PIIINP-positive type III collagen. The total amount of collagen, as indicated by reticulin staining, was increased in the subepithelial area beneath the BM. In papillomas, the mRNA levels for type I ( Figure 2D ) and type III collagens ( Figure 2E) were higher than those observed in simple dysplasia, forming a sheet-like band below the BM. Smooth muscle antigen (SMA) expression was also distinct, indicating the occurrence of myobroblasts.
Tracheobronchia l Squamous Cell Carcinomas
The predominant tumor type induced by DBC in the trachea and bronchi was squamous cell carcinoma (SCC) ( Figure 1 ) of varying degrees of differentiation. Slowly growing, malignant, well-differentiated grade 1 carcinomas consisted of solid sheets of squamous cells with large horn cysts in a collagen-containing ECM. Collagen type I mRNA ( Figure 2F ) and type III mRNA signals, as measured by in situ hybridization, were distinct in the stroma in the immediate vicinity of the epithelial tumor islets.
Malignant progression was associated with a distinct increase in deposition of ECM brillary components. Thick, occasionally hyalinized bundles of lamentous structures positive for type I procollagen were observed in the stroma adjacent to the epithelial structures ( Figure 3D ), compared with controls ( Figure 3E ). These neoplasms exhibited an expansive growth pattern, with collagen type I-and collagen type III-containing reticulin in the immediate vicinity of the epithelial tumor cells.
Moderately differentiated, grade 2, squamous cell carcinomas consisted of squamous cells with individual keratinization arranged in islets extending into the surrounding ECM ( Figure 2G ). Ultrastructural analysis revealed irregular lamentous structures in the tumor stroma ( Figure 2H ). Collagen type I mRNA and type III mRNA signals were localized to the ECM more distantly than the epithelial islets ( Figure 2I) .
A decrease in degree of differentiation of squamous cell carcinomas was associated with a decrease in deposition of collagens adjacent to epithelial islets. A decrease of PIIINPpositive type III procollagen bers and PINP-positive type I procollagen bers and destruction of ICTP-positive procollagen type I bers ( Figures 3F,G) was observed in the ECM adjacent to epithelial islets.
In less-differentiated (grade 3) neoplasms, ECM development was less distinct. These tumors consisted of irregular hyperchromatic cells devoid of glandular arrangements or keratin expression. The tumor islet cells were surrounded by loose ECM (Figure 2J ), containing fairly few bers. Collagen synthesis, as measured by in situ hybridization for collagen types I and III when compared with controls ( Figure 2K ), was less distinct ( Figure 2L ).
Solid tumor islets were associated with aberrant ECM, with thick irregular bers, signi cantly larger than those in unaltered matrix ( Figures 3H, 3I ), consisting of collagen type I-and type III-containing reticulin. Reticulin-positive bers were more distinct, indicating the occurrence of collagenous laments other than typical type I and type III collagens. Deposits of myo broblasts were less distinct, as revealed by scanty staining for SMA ( Figure 3J ).
Alveolar Neoplasms
Epithelial neoplastic growth along alveolar surfaces was also distinct. The lungs in both groups bore diffuse, or sometimes focal, peripheral proliferative lesions, which developed around the bronchus and followed the alveolar structure an adenomatoid pattern ( Figure 4A ). Glandular structures exhibited distinct cytological atypia and a scanty ECM ( Figure 4B) .
These adenocarcinomas showed a prominent but thin ECM containing collagen type I ( Figure 5A ) and type III. Growth into surrounding stroma produced an increase in collagen deposits ( Figure 5B ) and smooth muscle antigen-positive Figure 3F , ICTP 1,000, H Irregular collagen type III-positive bers in SCC grade 2, PIIINP 240, I High power view of the same tumor as in Figure 3H , PIIINP 1,000, J smooth muscle antigen expression in SCC grade 3, SMA 240. myo broblasts ( Figure 5C ). Extended growth and increased cellular atypia was associated with deposits of irregular collagen-containing reticulin-positive structures ( Figure 5D ) with discontinuous thickened or club-like bers ( Figure 5E ).
Neoplasms of the Pulmonary Lining Surface
Epithelial proliferative lesions of the pulmonary lining surface were lesions with a different collagen pro le. They exhibited cellular atypia, nuclear irregularities and hyperchromatism. These nodular excrescences of the pulmonary lining contained brillary as well as epithelial ( Figure 4C) components. These lesions progressed to malignant neoplasms invading the lung. Fully developed neoplasms consisted of pleomorphic cells with sparse keratin formation, arranged in diffuse cords in the stroma ( Figure 4D ). Collagen type I mRNA ( Figure 4E ) and type III mRNA ( Figure 4F ) signals, as measured by in situ hybridization, were distinct in the stroma in the immediate vicinity of the epithelial tumor islets.
Collagen structures formed an intimate part of the neoplasm, and more differentiated neoplasms also contained mucin ( Figure 5G ). The ECM consisted of irregular, thickened, type I-and type III-positive bers ( Figure 5H ). Procollagen-positive structures were arranged in bundles encircling groups of epithelial cells ( Figure 5I ).
Morphometric Characteristics of Collagenous ECM
The size of the area of collagen exceeding the predetermined threshold in relation to the total area of the lesion was measured by automated image analysis. The total volume of collagen as measured by the CAS200 QPI program was related to the stage of neoplasm development ( Figure 6 ). The data indicated an increase in collagen volume from the nonneoplastic state to dysplasia and further to well differentiated squamous cell carcinoma. Total collagen volume decreased with increasing degree of malignancy from well-to moderately differentiated squamous cell carcinoma, and in less-differentiated neoplasms. 
Morphometric Characteristics of Individual Collagen Fibers
Collagen structure, size and shape were also measured by computer-assisted image analysis of collagen type IIIpositive bers. Morphometric values were distinctly dependent on the morphological type of the lesion (Figure 7) .
The average optical density, indicating intensity of staining of type III collagen ( Figure 7A ), showed increased immunoreactivity in dysplasia and in well-differentiated squamous cell carcinoma, similarly to the increase in total collagen, as previously described. A decrease in staining intensity was observed in relation to the dedifferentiation of squamous cell carcinomas, similarly to the decrease in total collagen volume.
Fiber size, the area of positive PIIINP staining of individual bers, is reported as the ratio of collagen ber size in the lesion studied to the mean of collagen ber size in normal tissue ( Figure 7B ). Altered size of collagen bers was most distinct in moderately differentiated carcinomas, indicating proliferation of aberrant collagens. Collagen deposits were also irregular in undifferentiated small cell neoplasms. The ECM in these neoplasms consisted of accumulations of tiny bers ( Figure 7B ). Quantitative alterations in collagen shape speci c to the different lesions were not identi ed ( Figure 7C ), possibly as a result of the occurrence of different types of collagen ber in any one area.
To determine the characteristics of individual collagen bers, the mean, standard deviation and 95% con dence intervals of the means were calculated for measurements of size, shape and intensity of collagen staining in image analysis. Fiber shape alterations increased with increased ber size ( Figure 8 ) Comparison of collagen staining intensity and ber size showed the staining intensity to be similar regardless of ber size. Comparison of staining intensity and ber shape also yielded a similar result, with staining intensity being similar in bers of different shape.
Expression of TGFb
To examine the role of collagen synthesis regulation and collagen deposition, the expression of TGFb immunoreactivity ( Figure 9 ) was examined and compared with morphology, cell proliferation, and p53 expression. The tumors were stained through the use of antibodies to isoenzymes of TGFb (TGFb 1, TGFb 2, and TGFb 3) and the staining pattern was compared with localization of the p53 antibody CM5 and the PCNA antibody PC10.
In metaplastic and hyperplastic tracheobronchial epithelia, TGFb 1 immunoreactivity was strong in surface epithelial cells. In dysplasia, TGFb 1 immunostaining was absent in tracheobronchial epithelial cell layers, showing cytological atypia. TGFb 2 stained epithelial cell layers ( Figure 10A ) that expressed PCNA and p53, whereas TGFb 3 was more distinct in the super cial cell layers ( Figure 10B ). TGFb 3 staining was localized to super cial epithelial structures ( Figure 10C ); less so in dysplastic cells. TGFb 3 expression was also distinct in the stroma immediately beneath the epithelium in areas of increased collagen deposition and increased numbers of myo broblasts, as indicated by increased staining for SMA ( Figure 3C) .
In well-differentiated squamous cell carcinomas, TGFb 1positive nuclei were most numerous in perimembranous locations in the central cell layers (Figure 10D ), which were devoid of PCNA immunoreactivity. TGFb 2 stained atypical cells ( Figure 10E ), which were also positive for PCNA and p53. Increased TGFb 3 immunoreactivity occurred in the stroma ( Figure 10F ) concomitantly with an increase in collagen deposition, being prominent in malignant cells invading the surrounding stroma. In moderately well-differentiated neoplasms ( Figure 10G ), TGFb 2 expression was observed in neoplastic cells. In less well-differentiated neoplasms, TGFb 2 expression remained in a few malignant cells ( Figure 10H ), whereas TGFb 3 activity remained in alvelolar ECM ( Figure 10I ). Automated image analysis of TGFb expression showed increased TGFb 1 expression in epithelium compared with stroma ( Figure 9A ). No distinct correlation to lesion morphology was observed, however. TGFb 2 expression increased in proliferating epithelial cells during neoplasm progression ( Figure 9B ), occurring in cells expressing PCNA and p53. TGFb 2 immunoreactivity was present in most tumor cells, being lower in the ECM and in differentiated horn pearls in well differentiated squamous cell carcinomas. TGFb 3 expression was distinct in the ECM ( Figure 9C ) and in tumor cells.
DISCUSSION
A distinct increase in the amount of brillary structures in the adjacent stroma was characteristic of preneoplastic tracheobronchial lesions, epithelial hyperplasia and dysplasia, in this study. These early occurring alterations in the ECM have not been previously described in this manner and could partly explain the rapid progression of respiratory tracheobronchial epithelial lesions. In well differentiated squamous cell carcinomas of the lung, an increase in collagen deposition and synthesis was distinct, as in other human neoplasms (26) . In this expansive growth pattern, interstitial collagens were distributed as thick bands adjacent to the epithelial border, with distinct staining of PINP and PIIINP. This could also be interpreted as a host defense mechanism inhibiting the spread of the neoplasm (26). Distinct irregular collagen deposits were hallmarks of the ECM in moderately differentiated squamous cell carcinomas. Focal collagen ber destruction and a decrease in the positive staining of bers were observed in the immediate vicinity of invading tumor islets. Collagen destruction could be due to the action of enzymes, such as metalloproteases (63, 66) . The action of these enzymes has been considered a prerequisite for tumor growth and progression, as seen in other types of tumor in man (26) and experimental animals (62) . In less-differentiated squamous cell carcinomas, the matrix components and isolated squamous cells were occasionally mixed. Areas of matrix disintegration, cellular proliferation, and the formation of abortive structures occurred in the same neoplasm (27) . This nding is consistent with the concept that tumor stroma actively participates in malignant progression (3, 30, 73) . The stage-dependent alterations in volume and structure of speci c ECM components have not been previously described.
Characteristics of individual bers were also assessed in this study, revealing alterations related to neoplastic growth pattern and degree of tumor differentiation. Collagen staining intensity was increased in moderately differentiated squamous cell carcinomas and decreased with decreasing degree of differentiation. Collagen ber size was also increased, decreasing in less differentiated squamous cell carcinomas. These ndings are consistent with previously presented ndings on matrix participation in tumor growth (26, 27) . Collagen shape alterations failed to show correlation to tumorigenesis, possible because of the large variations in cell structure in the different lesions.
Image analysis of characteristics of collagen bers showed staining intensity to be similar in bers of different sizes and shape; thus, speci c quantitative staining characteristics of bers were not observed. Shape alterations increased with increasing ber size, indicating concomitant development of aberrations in neoplastic progression. The morphometric characteristics of collagen bres are mostly unknown, and further studies are needed to determine the clinical signicance of these ndings.
Altered TGFb expression was associated with malignancy in lung tumor development, as in human neoplasia (6, 32, 41, 65, 67) . Five distinct TGFb genes, designated TGFb 1-5, have been identi ed (31) . Each gene encodes a distinct peptide, which dimerizes to form an inactive TFGb precursor protein. Each TGFb is secreted as a latent complex, in association with its latency-associated peptide. TGFb immunoreactivity was associated with neoplastic progression depending upon isoform, in this study. TGFb 1 was present in differentiated cells, as in skin carcinogenesis (9, 11, 15, 18, 71) , whereas little or no reactivity was found in undifferentiated small cell tumors, as reported earlier (32) . TGFb 2 expression, observed in malignant lung tumor cells in this study, is frequently associated with an unfavorable prognosis in man (6, 32, 41, 65, 67) . TGFb 3 expression was also observed in the matrix in this study, and this isoform has also been implicated in collagen formation (19) .
The automated image analysis system used in this study made possible accurate, reproducible measurements in a large amount of material. Quantitative morphometric techniques have proved to be useful for immunohistochemical characterization of neoplasms, eg, breast (1, 10) and renal cancers (28) . Studies using automated image analysis in classi cation of neoplasms (70) have shown a sensitivity of 85% to 99%, a speci city of 86% to 98% and a positive predictive value of 87% to 97%. Variability in automated image analysis (42) has been due to specimen variability in systematic sampling in 92% of the cases and specimen variability in selective sampling in 67%. Technical variability has been responsible for 10% of the differences. The importance of sampling schemes and selection criteria has been shown (58) . Compared with visual scoring methods, automated image analysis is an improvement (5, 54) , provided that adequate precautions are taken. Immunohistochemical analysis is also associated with other problems, eg, relating to speci city and sensitivity of antibodies, effect of xation on preservation of epitopes, duration of antibody exposure, effect of pretreatments and role of antibody enhancement procedures (62) .
The results of the present experiments show the highly carcinogenic effects of DBC, making it useful for the experimental induction of respiratory tract tumors (55) (56) (57) . A total dose of only 9 mg caused more malignant respiratory tract tumors in hamsters, 72%, than have been found in the classical model using B(a)P and Fe 2 O 3 , where only 30% of the animals had tumors (36) . Tumor formation was not FIGURE 10.-TGFb immunoreactivity in tracheobronchia l epithelium and squamous cell carcinoma. A TGFb 2 immunoreactivity in dysplastic tracheobronchia l epithelium, TGFb 2 500, B TGFb 3 immunoreactivity in dysplastic tracheobronchia l epithelium, TGFb 3 600, C TGFb 2 immunoreactivity in dysplastic tracheobronchia l epithelium, TGFb 2 600, D TGFb 1 immunoreactivit y in tumor cells in well differentiated squamous cell carcinoma, TGFb 1 240, E TGFb 2 immunoreactivit y in tumor cells in moderately well differentiated squamous cell carcinoma, TGFb 2 600, F TGFb 3 immunoreactivity in stroma of moderately differentiated squamous cell carcinoma, TGFb 3 400, G TGFb 2 immunoreactivity in tumor cell in moderately well-differentiated squamous cell carcinoma, TGFb 2 400, H TGFb 2 immunoreactivity in tumor cells in less well differentiated squamous cell carcinoma, TGFb 2 500, I TGFb 3 immunoreactivit y in alveolar ECM of moderately differentiated squamous cell carcinoma, TGFb 3 240. dose-dependent (group 1 vs group 2) in this study. The lower dose was more carcinogenic, possibly due to the toxic effects of DBC on the tracheobronchial surface epithelium. Morphologically, the tumors in this study were similar to those seen in man. Most neoplasms were squamous cell carcinomas, and the stem bronchi and trachea seemed to be the preferential sites for the tumors. Adenocarcinomas, less common in this study, showed less distinct ECM changes. Mesotheliomas associated with asbestos exposure in man (69), show similarities to the neoplasms induced by the tobacco component DBC in this study.
In conclusion, the model of respiratory tumor development with known endpoints used in this study showed similarities to human tumor formation, making it a good model for lung cancer research. Stromal changes occurring during tumor development were directly associated with the neoplastic response, increasing with increasing degree of malignancy.
This may be interpreted as host defense. The minimal collagen deposition seen in small cell tumors could explain the rapid growth of these tumors.
